Sign in
Stories
Assertio Lawsuit Impact: Stock Decline
Share
Alleged Investor Misconduct Lawsuits Ale...
Alleged Misconduct Spurs Class Actions
Assertio Faces Lawsuit Amid Stock Declin...
AVXL Lawsuit: Deceptive Practices Expose...
Akero Lawsuit: Stock Impact Concerns
Altimmune Faces Investor Investigation
Overview
API
A securities class action lawsuit has been filed against Assertio Holdings, Inc. by Kessler Topaz Meltzer & Check, LLP for alleged securities law violations. Assertio's misleading statements resulted in investor losses. The approval of a generic version of Assertio's product by Zydus Lifesciences Limited led to a decline in stock price.
Ask a question
How does the generic product approval reflect broader trends in the pharmaceutical industry?
How might the lawsuit impact Assertio's reputation and future business operations?
What strategies could Assertio employ to recover from the stock price decline?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Coverage